248 related articles for article (PubMed ID: 25485740)
1. Endoscopic pneumatic dilation versus botulinum toxin injection in the management of primary achalasia.
Leyden JE; Moss AC; MacMathuna P
Cochrane Database Syst Rev; 2014; 2014(12):CD005046. PubMed ID: 25485740
[TBL] [Abstract][Full Text] [Related]
2. Endoscopic pneumatic dilation versus botulinum toxin injection in the management of primary achalasia.
Leyden JE; Moss AC; MacMathuna P
Cochrane Database Syst Rev; 2006 Oct; (4):CD005046. PubMed ID: 17054234
[TBL] [Abstract][Full Text] [Related]
3. Treatment of achalasia: botulinum toxin injection vs. pneumatic balloon dilation. A prospective study with long-term follow-Up.
Allescher HD; Storr M; Seige M; Gonzales-Donoso R; Ott R; Born P; Frimberger E; Weigert N; Stier A; Kurjak M; Rösch T; Classen M
Endoscopy; 2001 Dec; 33(12):1007-17. PubMed ID: 11740642
[TBL] [Abstract][Full Text] [Related]
4. Botulinum toxin versus pneumatic dilatation in the treatment of achalasia: a randomised trial.
Vaezi MF; Richter JE; Wilcox CM; Schroeder PL; Birgisson S; Slaughter RL; Koehler RE; Baker ME
Gut; 1999 Feb; 44(2):231-9. PubMed ID: 9895383
[TBL] [Abstract][Full Text] [Related]
5. Intrasphincteric botulinum toxin versus pneumatic balloon dilation for treatment of primary achalasia.
Bansal R; Nostrant TT; Scheiman JM; Koshy S; Barnett JL; Elta GH; Chey WD
J Clin Gastroenterol; 2003 Mar; 36(3):209-14. PubMed ID: 12590230
[TBL] [Abstract][Full Text] [Related]
6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
7. Long-term results of endoscopic injection of botulinum toxin in elderly achalasic patients with tortuous megaesophagus or epiphrenic diverticulum.
Wehrmann T; Kokabpick H; Jacobi V; Seifert H; Lembcke B; Caspary WF
Endoscopy; 1999 Jun; 31(5):352-8. PubMed ID: 10433043
[TBL] [Abstract][Full Text] [Related]
8. Meta-analysis of randomized and controlled treatment trials for achalasia.
Wang L; Li YM; Li L
Dig Dis Sci; 2009 Nov; 54(11):2303-11. PubMed ID: 19107596
[TBL] [Abstract][Full Text] [Related]
9. Achalasia: treatment options revisited.
Hoogerwerf WA; Pasricha PJ
Can J Gastroenterol; 2000 May; 14(5):406-9. PubMed ID: 10851281
[TBL] [Abstract][Full Text] [Related]
10. Laparoscopic Heller myotomy is not superior to pneumatic dilation in the management of primary achalasia: Conclusions of a systematic review and meta-analysis of randomized controlled trials.
Cheng JW; Li Y; Xing WQ; Lv HW; Wang HR
Medicine (Baltimore); 2017 Feb; 96(7):e5525. PubMed ID: 28207499
[TBL] [Abstract][Full Text] [Related]
11. Achalasia: what is the best treatment?
Ahmed A
Ann Afr Med; 2008 Sep; 7(3):141-8. PubMed ID: 19253525
[TBL] [Abstract][Full Text] [Related]
12. Randomized controlled trial comparing botulinum toxin injection to pneumatic dilatation for the treatment of achalasia.
Mikaeli J; Fazel A; Montazeri G; Yaghoobi M; Malekzadeh R
Aliment Pharmacol Ther; 2001 Sep; 15(9):1389-96. PubMed ID: 11552910
[TBL] [Abstract][Full Text] [Related]
13. Comparison of pneumatic dilation with pneumatic dilation plus botulinum toxin for treatment of achalasia.
Bakhshipour A; Rabbani R; Shirani S; Soleimani HA; Mikaeli J
Acta Med Iran; 2010; 48(2):107-10. PubMed ID: 21133003
[TBL] [Abstract][Full Text] [Related]
14. Use of botulinum toxin in the treatment of achalasia.
Schiano TD; Parkman HP; Miller LS; Dabezies MA; Cohen S; Fisher RS
Dig Dis; 1998; 16(1):14-22. PubMed ID: 9549033
[TBL] [Abstract][Full Text] [Related]
15. Treatment of achalasia: the short-term response to botulinum toxin injection seems to be independent of any kind of pretreatment.
Storr M; Born P; Frimberger E; Weigert N; Rösch T; Meining A; Classen M; Allescher HD
BMC Gastroenterol; 2002 Aug; 2():19. PubMed ID: 12175425
[TBL] [Abstract][Full Text] [Related]
16. Botulinum toxin treatment of oesophageal achalasia in the old old and oldest old: a 1-year follow-up study.
Dughera L; Battaglia E; Maggio D; Cassolino P; Mioli PR; Morelli A; Emanuelli G; Bassotti G
Drugs Aging; 2005; 22(9):779-83. PubMed ID: 16156681
[TBL] [Abstract][Full Text] [Related]
17. The role of Botulinum toxin injection in the management of achalasia.
Ramzan Z; Nassri AB
Curr Opin Gastroenterol; 2013 Jul; 29(4):468-73. PubMed ID: 23695428
[TBL] [Abstract][Full Text] [Related]
18. Long-term results and prognostic factors in the treatment of achalasia with botulinum toxin.
Neubrand M; Scheurlen C; Schepke M; Sauerbruch T
Endoscopy; 2002 Jul; 34(7):519-23. PubMed ID: 12170400
[TBL] [Abstract][Full Text] [Related]
19. Short and medium-term therapeutic effects of pneumatic dilatation for achalasia: a 15-year tertiary centre experience.
Andreevski V; Nojkov B; Krstevski M; Genadieva Dimitrova M; Joksimovik N; Serafimoski V
Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2013; 34(2):15-22. PubMed ID: 24285349
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcomes of balloon dilation versus botulinum toxin injection in patients with primary achalasia.
Jung HE; Lee JS; Lee TH; Kim JN; Hong SJ; Kim JO; Kim HG; Jeon SR; Cho JY
Korean J Intern Med; 2014 Nov; 29(6):738-45. PubMed ID: 25378972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
